SANEPAR is trading 3.53% up at BRL 6.46, with no clear company-specific announcement identified to explain the August 20, 2026 gain.

  • Agepar’s August 19 decision rejected Sanepar’s appeal over tariff-discount terms but granted a 30-day implementation extension.
  • The regulatory update was mixed rather than an obvious catalyst for today’s advance.
  • Trading volume and activity details were unavailable.